Advanced search
Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 25, 2018 - Issue 1
Submit an article Journal homepage
372
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis

Parameswaran HariDepartment of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; View further author information
,
Huamao Mark LinMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; Correspondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8399-8966View further author information
ORCID Icon,
Carl V. AscheCenter for Outcomes Research, Department of Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA; ;Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; View further author information
,
Jinma RenCenter for Outcomes Research, Department of Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA; ORCID Iconhttps://orcid.org/0000-0002-4616-476XView further author information
ORCID Icon,
Candice YongMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information
,
Katarina LuptakovaMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information
,
Douglas V. FallerMillennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA; View further author information
&
Vaishali SanchorawalaAmyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USAORCID Iconhttp://orcid.org/0000-0002-6307-2445View further author information
ORCID Icon show all
Pages 1-7 | Received 20 Jul 2017, Accepted 24 Nov 2017, Published online: 05 Jan 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Angela Dispenzieri, Jeffrey Zonder, James Hoffman, Sandra W. Wong, Michaela Liedtke, Rafat Abonour, Anita D’Souza, Charlene Lee, Sarah Cote, Ravi Potluri, Eric Ammann, NamPhuong Tran, Annette Lam & Sandhya Nair. (2023) Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases. Amyloid 30:2, pages 161-168.
Read now
Marco Basset, Mario Nuvolone, Giovanni Palladini & Giampaolo Merlini. (2020) Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside. Expert Review of Hematology 13:9, pages 1003-1015.
Read now
Peter Mollee, Simon Gibbs & Graeme Stewart. (2019) Amyloidosis in Australia. Expert Opinion on Orphan Drugs 7:2, pages 37-39.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.